General practitioners in England and Wales will soon offer two new NHS-funded diagnostic tests to identify endometriosis [1].

These tools aim to shorten the time patients wait for a diagnosis and reduce the reliance on invasive surgical procedures to confirm the condition. The current average diagnostic delay for endometriosis is nine years [2].

The National Health Service is introducing two specific tests to address this gap [3]. The first is Endotest, which is a saliva-based diagnostic tool [4]. The second is a gut-sensor test known as EndoSure [3, 4].

By providing these options at the primary care level, the NHS intends to streamline the patient pathway. Currently, many patients must undergo laparoscopy, an invasive surgical procedure, to receive a definitive diagnosis. The introduction of non-invasive alternatives could allow GPs to spot the condition earlier in the clinical process.

Medical officials said the rollout is a potential game-changer for women's health in the region [5]. While a specific start date for the nationwide rollout has not been provided, the tests are expected to be available in the near future [6].

Endometriosis occurs when tissue similar to the lining of the uterus grows outside the womb. This can cause severe pain and fertility issues, making early detection critical for effective pain management, and treatment planning [4].

“The current average diagnostic delay for endometriosis is nine years.”

The shift toward non-invasive diagnostics like Endotest and EndoSure represents a move to decentralize specialist screenings. By moving the initial diagnostic phase from surgical theaters to GP clinics, the healthcare system can potentially reduce the burden on surgical waiting lists and improve long-term patient outcomes through earlier intervention.